首页 › 基金 › Acasta Partners UK LLP › VRDN
Acasta Partners UK LLP 对 VRDN 的持仓历史
VIRIDIAN THERAPEUTICS INC · 医疗保健
Acasta Partners UK LLP 在 Q3 2026 的 13F 申报中披露持有 VRDN(VIRIDIAN THERAPEUTICS INC)5,000,000 股,市值约 US$5.7M,约占其申报组合的 3.00%,在其申报持仓中市值排名第 7 位。 Acasta Partners UK LLP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Acasta Partners UK LLP 对 VRDN 的持仓演变
Acasta Partners UK LLP 于 Q3 2026 首次披露 VRDN 持仓:5,000,000 股(约 US$5.7M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 5.00M | $5.74M | 新进 |
关于 VRDN 与 13F 数据
VRDN(VIRIDIAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 VRDN,申报仓位最大的包括:Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VRDN 的基金
- Bellevue Group AG 6.73M 股 · $123.67M · Q2 2026
- Paradigm Biocapital Advisors LP 6.72M 股 · $123.52M · Q2 2026
- Kynam Capital Management, LP 6.45M 股 · $118.56M · Q2 2026
- Fairmount Funds Management LLC 5.09M 股 · $93.52M · Q2 2026
- Deep Track Capital, LP 3.59M 股 · $66.00M · Q2 2026
- Venrock Adviser, LLC 3.26M 股 · $59.85M · Q2 2026
- Avoro Capital Advisors LLC 2.50M 股 · $45.92M · Q2 2026
- Context Capital Management, LLC 40.75M 股 · $43.82M · Q2 2026
- BAKER BROS. ADVISORS LP 2.38M 股 · $43.78M · Q2 2026
- Caligan Partners LP 2.19M 股 · $40.30M · Q2 2026
- Novo Holdings A/S 2.13M 股 · $39.22M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.79M 股 · $32.93M · Q2 2026
更多关于 Acasta Partners UK LLP
常见问题
How long has Acasta Partners UK LLP held VRDN?
Acasta Partners UK LLP has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Acasta Partners UK LLP's current position in VRDN?
As of Q3 2026, Acasta Partners UK LLP holds 5.00M shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $5.74M, representing 3.00% of its reported portfolio and ranking #7.
Has Acasta Partners UK LLP been buying or selling VRDN?
In the latest 13F filing (Q3 2026), Acasta Partners UK LLP newly opened its position in VRDN.
Which other funds hold VRDN?
Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.